Oncology Institute Inc.
TOI | NASDAQ
$5.13
-$1.26 (-19.72%)
At close: Aug 03, 2026, 04:00 PM ET
Fiscal Quarter Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 161.28M | 147.44M | 141.96M | 136.56M | 119.8M | 104.41M | 100.27M | 99.9M | 98.58M | 94.67M | 85.79M | 82.04M | 80.22M | 76.19M | 71.42M | 64.98M | 60.92M | 55.16M | 52.3M | 52.28M | 49.84M | 48.58M |
Cost of Revenue | n/a | 125.74M | 119.19M | 117.64M | 102.3M | 87.16M | 85.63M | 85.54M | 85.55M | 82.7M | 71.41M | 66.06M | 65.11M | 62.09M | 55.8M | 51.98M | 49.78M | 42.84M | 43.97M | 40.85M | 38.95M | 38.38M |
Gross Profit | n/a | 21.7M | 22.77M | 18.92M | 17.5M | 17.25M | 14.64M | 14.37M | 13.03M | 11.97M | 14.38M | 15.98M | 15.12M | 14.1M | 15.63M | 13M | 11.14M | 12.32M | 8.33M | 11.42M | 10.89M | 10.2M |
Operating Income | -4.62M | -6.51M | -6.91M | -8.05M | -11.21M | -9.91M | -11.93M | -13.85M | -16.36M | -17.97M | -15.29M | -13.93M | -14.94M | -32.87M | -25.08M | -20.1M | -18.3M | -18.47M | -40.83M | -2.16M | -1.12M | -1.75M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 940K | 1.03M | 1.21M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -9.79M | -2.49M | -7.51M | -16.5M | -17.14M | -19.59M | -13.18M | -16.11M | -15.48M | -19.89M | -19.07M | -17.28M | -16.8M | -29.95M | -11.37M | -2.7M | -5.49M | 19.47M | -12.62M | -2.18M | 3.99M | -778K |
Net Income | -9.79M | -2.49M | -7.51M | -16.5M | -17.01M | -19.59M | -13.18M | -16.11M | -15.48M | -19.89M | -18.75M | -17.42M | -16.9M | -30M | -11.01M | -2.67M | -5.45M | 19.29M | -10.16M | -2.98M | 3.21M | -996K |
Selling & General & Admin | 29.94M | 28.21M | 28.04M | 25.25M | n/a | 25.38M | 24.86M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 31.96M | 28.35M | 29.81M | 48.25M | 12.73M | 11.21M | 11.18M |
Research & Development | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Expenses | 135.96M | n/a | 1.63M | 1.72M | 28.71M | 1.78M | 1.71M | 28.22M | 29.39M | 29.94M | 29.67M | 29.9M | 30.06M | 46.97M | 40.71M | 1.13M | 1.1M | 987K | 920K | 850K | 794K | 777K |
Operating Expenses | 165.9M | 28.21M | 29.67M | 26.97M | 28.71M | 27.16M | 26.57M | 28.22M | 29.39M | 29.94M | 29.67M | 29.9M | 30.06M | 46.97M | 40.71M | 33.1M | 29.45M | 30.79M | 49.17M | 13.58M | 12.01M | 11.96M |
Interest Expense | 1.86M | 1.93M | 1.92M | 1.92M | 1.87M | 5.57M | 1.17M | 2.23M | 2.12M | 1.99M | 1.94M | 2.7M | 2.67M | 2.65M | 2.45M | 1.5M | 61K | 74K | 60K | 78K | 81K | 101K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 11.2M | n/a | n/a |
Cost & Expenses | n/a | 153.95M | 148.86M | 144.62M | 131.01M | 114.32M | 112.2M | 113.75M | 114.94M | 112.64M | 101.08M | 95.96M | 95.16M | 109.06M | 96.5M | 85.07M | 79.23M | 73.63M | 93.14M | 54.43M | 50.96M | 50.33M |
Income Tax Expense | n/a | n/a | n/a | n/a | -131K | n/a | n/a | n/a | n/a | n/a | -314K | 135K | 99K | 44K | -367K | -24K | -32K | 180K | -2.47M | 799K | 780K | 218K |
Shares Outstanding (Basic) | 1.03B | 1.02B | 1.01B | 974.75M | 932.04M | 77.1M | 75.66M | 75.52M | 74.75M | 74.23M | 73.47M | 73.47M | 74.12M | 73.45M | 72.75M | 79.58M | 73M | 73.25M | 69.95M | 74.59M | 66.02M | 66.02M |
Shares Outstanding (Diluted) | 1.03B | 1.02B | 1.01B | 974.75M | 932.04M | 77.1M | 75.66M | 75.52M | 74.75M | 74.23M | 73.47M | 73.47M | 74.12M | 73.45M | 85.59M | 79.58M | 73M | 76.25M | 69.95M | 74.59M | 66.02M | 66.02M |
EPS (Basic) | -0.08 | -0.02 | -0.04 | -0.14 | -0.15 | -0.21 | -0.14 | -0.18 | -0.17 | -0.22 | -0.21 | -0.19 | -0.23 | -0.41 | -0.13 | -0.03 | -0.07 | 0.22 | -0.15 | -0.04 | 0.05 | -0.02 |
EPS (Diluted) | -0.08 | -0.02 | -0.04 | -0.14 | -0.15 | -0.21 | -0.14 | -0.18 | -0.17 | -0.22 | -0.21 | -0.19 | -0.23 | -0.41 | -0.11 | -0.03 | -0.07 | 0.21 | -0.15 | -0.04 | 0.05 | -0.02 |
EBITDA | -2.78M | 1.06M | -3.96M | -12.86M | -13.47M | -12.23M | -10.31M | -12.32M | -11.84M | -16.42M | -13.82M | -12.19M | -13.55M | -14.73M | -14.64M | -67K | -4.33M | 20.53M | -11.64M | -1.25M | 4.86M | 100K |
EBIT | n/a | -558K | -5.59M | -14.58M | -15.27M | -14.02M | -12.01M | -13.89M | -13.36M | -17.9M | -15.4M | -13.88M | -14.88M | -16M | -15.83M | -1.2M | -5.42M | 19.54M | -12.56M | -2.1M | 4.07M | -677K |
Depreciation & Amortization | 1.84M | 1.62M | 1.63M | 1.72M | 1.81M | 1.78M | 1.71M | 1.57M | 1.52M | 1.49M | 1.58M | 1.7M | 1.33M | 1.27M | 1.19M | 1.13M | 1.1M | 987K | 920K | 850K | 794K | 777K |
Add to Watchlist
Select watchlists to add or remove TOI